Table 1.
No. (%) of Patientsa |
||||
---|---|---|---|---|
Survival |
||||
Variable | All (N = 191) | ≥1 Year (n = 138) | <1 Year (n = 53) | P Value |
Cancer subsite | ||||
Larynx | 72 (37.7) | 56 (40.6) | 16 (30.2) | <.001b |
Oral cavity | 72 (37.7) | 50 (36.2) | 22 (41.5) | |
Oropharynx | 38 (19.9) | 27 (19.6) | 11 (20.8) | |
Hypopharyx | 9 (4.7) | 5 (3.6) | 4(7.5) | |
Sex | ||||
Female | 55 (28.8) | 40 (29.0) | 15 (28.3) | .93 |
Male | 136 (71.2) | 98 (71.0) | 38 (71.7) | |
Smoking history | ||||
Never | 27 (14.1) | 15 (10.9) | 12 (22.6) | .04b |
Former or current | 158 (82.7) | 118 (85.5) | 40 (75.5) | |
Alcohol history | ||||
None | 50 (26.2) | 35 (25.4) | 15 (28.3) | .95 |
Former or current alcohol history | 122 (63.9) | 86 (62.3) | 36 (67.9) | |
T stagec | ||||
1 | 72 (37.7) | 63 (45.7) | 9 (17.0) | <.001b |
2 | 61 (31.9) | 42 (30.4) | 19 (35.8) | |
3 | 35 (18.3) | 19 (13.8) | 16 (30.2) | |
4 | 19 (9.9) | 10 (7.2) | 9 (17.0) | |
N stagec | ||||
N0/1 | 135 (70.7) | 103 (74.6) | 32 (60.4) | .02b |
N2 or less | 46 (24.1) | 27 (19.6) | 19 (35.8) | |
Closure | ||||
Free flap | 30 (15.7) | 17 (12.3) | 13 (24.5) | .05b |
Primary closure or pedicledflap | 97 (50.8) | 73 (52.9) | 24 (45.3) | |
Primary radiotherapy | ||||
Yes | 93 (48.7) | 69 (50.0) | 24 (45.3) | .56 |
No | 98 (51.3) | 69 (50.0) | 29 (55.7) | |
Adjuvant therapy | ||||
None | 103 (53.9) | 80 (58.0) | 23 (43.4) | .009b |
Radiation | 31 (16.2) | 20 (14.5) | 11 (20.8) | |
Radiation and chemotherapy | 20 (10.5) | 9 (6.5) | 11 (20.8) | |
Disease-free interval,mo | ||||
<6 | 91 (47.6) | 56 (40.6) | 35 (66.0) | .002b |
≥6 | 100 (52.4) | 82 (59.4) | 18 (34.0) | |
Primary extracapsular spread | ||||
Yes | 17 (8.9) | 5 (3.6) | 12 (22.6) | .89 |
No | 8 (4.2) | 2 (1.4) | 6 (11.3) | |
HPV status | ||||
Positive | 9 (4.7) | 7 (5.1) | 2 (3.8) | .43 |
Negative | 25 (13.1) | 14 (10.1) | 11 (20.8) | |
Primary perineural invasion | ||||
Yes | 26 (13.6) | 14 (10.1) | 12 (22.6) | .20 |
No | 49 (25.7) | 35 (25.4) | 14 (26.4) | |
Primary mandible procedure | ||||
Yes | 20 (10.5) | 12 (8.7) | 8 (15.1) | .29 |
No | 144 (75.4) | 105 (76.1) | 39 (73.6) | |
Primary positive margin | ||||
Yes | 9 (4.7) | 6 (4.3) | 3 (5.7) | >.99 |
No | 74 (38.7) | 47 (34.1) | 27 (50.9) |
Total No. (%) discrepancies are a result of data points answered as unknown or not applicable.
Statistically significant (P < .05).
Staging of primary disease at the time of initial diagnosis.